These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
6533 related items for PubMed ID: 2272773
1. Esorubicin (deoxydoxorubicin) has low grade activity in malignant melanoma. Results of an Eastern Cooperative Oncology Group study (EST 2685). Hochster H, Hunt M, Green M, Parkinson D, Smith T. Invest New Drugs; 1990 Aug; 8(3):329-32. PubMed ID: 2272773 [Abstract] [Full Text] [Related]
2. Phase II study of esorubicin (4'-deoxydoxorubicin) in locally advanced or metastatic head and neck carcinoma. Frustaci S, Gasparini G, Veronesi A, Tirelli U, Pacciarini MA, Crivellari D, Zagonel V, Monfardini S. Invest New Drugs; 1987 Aug; 5(3):307-9. PubMed ID: 3667167 [Abstract] [Full Text] [Related]
5. Phase II trial of esorubicin (4' deoxydoxorubicin) in cancers of the breast, colon, kidney, lung and melanoma. Braich TA, Salmon SE, Robertone A, Alberts DS, Jones SE, Miller TP, Garewal HS. Invest New Drugs; 1986 Aug; 4(3):269-74. PubMed ID: 3818231 [Abstract] [Full Text] [Related]
9. Phase II trial of carboplatin in patients with metastatic malignant melanoma. A report from the Eastern Cooperative Oncology Group. Chang A, Hunt M, Parkinson DR, Hochster H, Smith TJ. Am J Clin Oncol; 1993 Apr; 16(2):152-5. PubMed ID: 8452109 [Abstract] [Full Text] [Related]
12. Activity of esorubicin in recurrent malignant lymphoma: a Southwest Oncology Group study. Miller TP, Dahlberg S, Salmon SE, Williamson SK, Belt RJ, Dana BW, Fisher RI. J Clin Oncol; 1991 Jul; 9(7):1204-9. PubMed ID: 2045860 [Abstract] [Full Text] [Related]
17. Piperazinedione in patients with advanced malignant melanoma: a Southwest Oncology Group study. Al-Sarraf M, Thigpen T, Groppe CW, Haut A, Padilla F. Cancer Treat Rep; 1978 Jul; 62(7):1101-3. PubMed ID: 356973 [Abstract] [Full Text] [Related]